Pepticom is participating in the BioDigital conference this week.
If you are interested to learn more on Pepticom’s AI peptide design & discovery technology, please contact Shoshi.Keynan@wordpress-544837-1818586.cloudwaysapps.com
Pepticom is fighting the corona virus
In the news: https://www.kan.org.il/Item/?itemId=69208
Pepticom is implementing its proprietary technology on various SARS-CoV-2 proteins and the ACE2
to identify novel inhibitors that can fight the COVID19. We are looking for partners to validate and develop these peptide drug candidates. For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com
Partner with us to fight the Corona virus!
https://www.israel21c.org/30-israeli-medical-tech-solutions-to-help-fight-coronavirus/ For more information : Shoshi.Keynan@wordpress-544837-1818586.cloudwaysapps.com
Dr. Shoshi Keynan , Pepticom’s VP BD will be attending BioEurope on March 23-25 in Paris.
Meet us and learn how Pepticom’s AI peptide design platform can augment your drug discovery process. For more information: shoshi.keynan@wordpress-544837-1818586.cloudwaysapps.com
Pepticom’s AI peptide design platform as part of “Lead Identification” in the drug discovery ecosystem
https://www.biopharmatrend.com/m/map/
Dr. Immanuel Lerner, Pepticom’s CEO, will present at “DISCOVERY on TARGET” Conference in Boston (September 25-28).
Dr. Lerner will discuss Pepticom’s exciting design work on TLR4 activators in “the Cyclic Peptide Design Challenges” session.
Pepticom’s CTO, Dr. Amit Michaeli, will present in the Boulder Peptide Symposium
The talk will take place on September 24 at 13:25.
Pepticom is pleased to announce that Pierre Riviere, Ph.D., has joined the company’s Scientific Advisory Board to advise Pepticom on its peptide therapeutics strategy, programs and business.
Dr. Riviere has over 25 years of biopharmaceutical industry experience with R&D leadership roles in target and drug discovery, nonclinical and early-stage clinical development. He is a recognized expert in peptide therapeutics with both established peptide modalities and emerging novel peptide technologies. Dr. Riviere is Founder and CEO of Peptide Logic, a San Diego-based biotech […]
Come and meet Pepticom’s CEO, Dr. Immanuel Lerner at the Bio 2018 conference in Boston, MA.
For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com.